Enzymatic process for the preparation of (S)-5-(4-fluoro-phenyl)-5-hydroxy-1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
The present invention provides an enzymatic process for the preparation of (S)-5-(4-Fluoro-phenyl)-5-hydroxy-Imorpholin-4-yl-pentan-1-one by the reduction of 1-(4-Fluoro-phenyl)-5-morpholin-4-yl-pentane-1,5-dione by using a suitable enzyme or by the resolution of (R, S)-5-(4-Fluoro-phenyl)-5-hydroxy-1 morpholin-4-yl-pentan-1-one by using an enzyme. The present invention also provides process for the preparation of Ezetimibe comprising the steps of a) protecting the compound (S)-5-(4-Fluoro-phenyl)-5-hydroxy-1 morpholin-4-yl-pentan-1-one with hydroxy protecting group b) hydrolyzing the obtained compound c) condensing with a chiral auxiliary d) reacting with an protected imine compound e) converting to alkyl ester f) cyclizing and g) deprotecting to obtain Ezetimibe.
1. A process for preparing ezetimibe comprising the steps of:
cyclizing a compound of formula 9 in the presence of a non-nucleophilic base to obtain an azetidinone compound of formula 10;
wherein
P 1 and P 2 are hydroxy protecting groups and at least one of P 1 and P 2 is a benzyl group; and
R 1 is C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, aryl, or substituted aryl; and
removing the hydroxy protecting groups.
2. The process of claim 1 , further comprising reacting a compound of formula 8 with an alkali metal alkoxide or aryloxide in a solvent to obtain the compound of formula 9;
wherein R is C 1 -C 6 alkyl, phenyl, naphthyl, substituted phenyl, substituted naphthyl, C 1 -C 6 alkoxycarbonyl or benzyl.
3. The process of claim 2 , further comprising reacting a compound of formula 6 with a protected imine compound of formula 7 in a solvent in the presence of an organic amine base and a Lewis acid to obtain the compound of formula 8
4. The process of claim 2 , further comprising recovering a chiral auxiliary of formula 5,
5. The process of claim 3 , further comprising recovering a chiral auxiliary of formula 5,
6. The process of claim 1 , wherein the non-nucleophilic base is lithium bis(trimethylsilyl)amide.
7. The process of claim 1 , wherein P 1 and P 2 are each a benzyl group.
8. The process of claim 1 , wherein P 1 and P 2 are each benzyl.
9. The process of claim 2 , wherein R is phenyl.
10. The process of claim 3 , wherein the organic amine base comprises diisopropylethylamine and the Lewis acid comprises TiCl 4 .